Acute Kidney Injury Stem Cell Treatments
A Regenerative Approach to Kidney Health
Acute Kidney Injury (AKI) is a sudden episode of kidney failure or kidney damage that occurs within a few hours or days. It causes waste products to build up in the blood, leading to imbalances in fluids, electrolytes, and acids, which can affect overall health. Traditional treatments focus on managing symptoms, supporting kidney function, and addressing underlying causes, but they may not fully repair damaged kidney tissue.
At 1 STEM CELL, we offer cutting-edge stem cell therapy for AKI aimed at regenerating kidney tissue, reducing inflammation, and restoring kidney function. Using umbilical cord–derived mesenchymal stem cells (MSCs), our protocol helps modulate immune response, promote tissue repair, and enhance recovery of renal function.
Unlike conventional therapies, stem cell treatment targets the root cause of kidney injury, offering patients the potential to accelerate recovery, reduce complications, and improve quality of life.
Questions and Answers About Stem Cell Therapy for Acute Kidney Injury
Q: How can stem cells help treat AKI?
Mesenchymal stem cells support kidney regeneration by promoting repair of damaged tissue, reducing inflammation, and regulating abnormal immune responses that contribute to kidney injury.
Q: Is this treatment safe?
Yes. All stem cells at 1 STEM CELL are ethically sourced, laboratory-tested, and administered under strict medical supervision to ensure safety and optimal results.
Q: How soon can improvements be noticed?
Some patients may notice improved kidney function and reduced fluid retention within a few weeks. Full recovery and normalization of kidney markers may take several months, depending on the severity of the injury.
Q: Does stem cell therapy replace conventional treatments?
Stem cell therapy may complement existing treatments and potentially reduce the need for certain medications. All treatment plans should be supervised by a qualified physician.
Q: Who qualifies for AKI stem cell therapy?
Candidates include patients with acute kidney injury who seek regenerative support for kidney recovery, especially those at risk of prolonged complications or insufficient response to conventional therapies.